Format
Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 153

1.

Synthesis, Structure Characterization, and Evaluation in Microglia Cultures of Neuromelanin Analogues Suitable for Modeling Parkinson's Disease.

Ferrari E, Capucciati A, Prada I, Zucca FA, D'Arrigo G, Pontiroli D, Bridelli MG, Sturini M, Bubacco L, Monzani E, Verderio C, Zecca L, Casella L.

ACS Chem Neurosci. 2017 Mar 15;8(3):501-512. doi: 10.1021/acschemneuro.6b00231.

PMID:
28292181
2.

Contrast mechanisms associated with neuromelanin-MRI.

Trujillo P, Summers PE, Ferrari E, Zucca FA, Sturini M, Mainardi LT, Cerutti S, Smith AK, Smith SA, Zecca L, Costa A.

Magn Reson Med. 2016 Dec 26. doi: 10.1002/mrm.26584. [Epub ahead of print]

PMID:
28019018
3.

Neuromelanin Imaging and Dopaminergic Loss in Parkinson's Disease.

Isaias IU, Trujillo P, Summers P, Marotta G, Mainardi L, Pezzoli G, Zecca L, Costa A.

Front Aging Neurosci. 2016 Aug 22;8:196. doi: 10.3389/fnagi.2016.00196.

4.

Elemental mapping of Neuromelanin organelles of human Substantia Nigra: correlative ultrastructural and chemical analysis by analytical transmission electron microscopy and nano-secondary ion mass spectrometry.

Biesemeier A, Eibl O, Eswara S, Audinot JN, Wirtz T, Pezzoli G, Zucca FA, Zecca L, Schraermeyer U.

J Neurochem. 2016 Jul;138(2):339-53. doi: 10.1111/jnc.13648.

PMID:
27121280
5.

Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease.

Zucca FA, Segura-Aguilar J, Ferrari E, Muñoz P, Paris I, Sulzer D, Sarna T, Casella L, Zecca L.

Prog Neurobiol. 2015 Oct 9. pii: S0301-0082(15)00101-X. doi: 10.1016/j.pneurobio.2015.09.012. [Epub ahead of print] Review.

PMID:
26455458
6.

Melanins and melanogenesis: from pigment cells to human health and technological applications.

d'Ischia M, Wakamatsu K, Cicoira F, Di Mauro E, Garcia-Borron JC, Commo S, Galván I, Ghanem G, Kenzo K, Meredith P, Pezzella A, Santato C, Sarna T, Simon JD, Zecca L, Zucca FA, Napolitano A, Ito S.

Pigment Cell Melanoma Res. 2015 Sep;28(5):520-44. doi: 10.1111/pcmr.12393. Review.

PMID:
26176788
7.

Norepinephrine and its metabolites are involved in the synthesis of neuromelanin derived from the locus coeruleus.

Wakamatsu K, Tabuchi K, Ojika M, Zucca FA, Zecca L, Ito S.

J Neurochem. 2015 Nov;135(4):768-76. doi: 10.1111/jnc.13237.

8.

The role of iron in brain ageing and neurodegenerative disorders.

Ward RJ, Zucca FA, Duyn JH, Crichton RR, Zecca L.

Lancet Neurol. 2014 Oct;13(10):1045-60. doi: 10.1016/S1474-4422(14)70117-6. Review.

PMID:
25231526
9.

Reduction of the nitro group to amine by hydroiodic acid to synthesize o-aminophenol derivatives as putative degradative markers of neuromelanin.

Wakamatsu K, Tanaka H, Tabuchi K, Ojika M, Zucca FA, Zecca L, Ito S.

Molecules. 2014 Jun 16;19(6):8039-50. doi: 10.3390/molecules19068039.

10.

Engineered nanoparticles. How brain friendly is this new guest?

Cupaioli FA, Zucca FA, Boraschi D, Zecca L.

Prog Neurobiol. 2014 Aug-Sep;119-120:20-38. doi: 10.1016/j.pneurobio.2014.05.002. Review.

PMID:
24820405
11.

MHC-I expression renders catecholaminergic neurons susceptible to T-cell-mediated degeneration.

Cebrián C, Zucca FA, Mauri P, Steinbeck JA, Studer L, Scherzer CR, Kanter E, Budhu S, Mandelbaum J, Vonsattel JP, Zecca L, Loike JD, Sulzer D.

Nat Commun. 2014 Apr 16;5:3633. doi: 10.1038/ncomms4633.

12.

Protective and toxic roles of dopamine in Parkinson's disease.

Segura-Aguilar J, Paris I, Muñoz P, Ferrari E, Zecca L, Zucca FA.

J Neurochem. 2014 Jun;129(6):898-915. doi: 10.1111/jnc.12686. Review.

13.

Neuromelanin of the human substantia nigra: an update.

Zucca FA, Basso E, Cupaioli FA, Ferrari E, Sulzer D, Casella L, Zecca L.

Neurotox Res. 2014 Jan;25(1):13-23. doi: 10.1007/s12640-013-9435-y. Review.

PMID:
24155156
14.

Human neuromelanin: an endogenous microglial activator for dopaminergic neuron death.

Zhang W, Zecca L, Wilson B, Ren HW, Wang YJ, Wang XM, Hong JS.

Front Biosci (Elite Ed). 2013 Jan 1;5:1-11.

15.

Neuromelanins of human brain have soluble and insoluble components with dolichols attached to the melanic structure.

Engelen M, Vanna R, Bellei C, Zucca FA, Wakamatsu K, Monzani E, Ito S, Casella L, Zecca L.

PLoS One. 2012;7(11):e48490. doi: 10.1371/journal.pone.0048490.

16.

Synthesis and structural characterization of soluble neuromelanin analogs provides important clues to its biosynthesis.

Ferrari E, Engelen M, Monzani E, Sturini M, Girotto S, Bubacco L, Zecca L, Casella L.

J Biol Inorg Chem. 2013 Jan;18(1):81-93. doi: 10.1007/s00775-012-0951-7.

PMID:
23111628
17.

Biosynthetic pathway to neuromelanin and its aging process.

Wakamatsu K, Murase T, Zucca FA, Zecca L, Ito S.

Pigment Cell Melanoma Res. 2012 Nov;25(6):792-803. doi: 10.1111/pcmr.12014.

PMID:
22938712
18.

Human immunodeficiency virus type 1 alters brain-derived neurotrophic factor processing in neurons.

Bachis A, Avdoshina V, Zecca L, Parsadanian M, Mocchetti I.

J Neurosci. 2012 Jul 11;32(28):9477-84. doi: 10.1523/JNEUROSCI.0865-12.2012.

19.

Use of psychiatric inpatient services by heavy users: findings from a national survey in Italy.

Morlino M, Calento A, Schiavone V, Santone G, Picardi A, de Girolamo G; PROGRES-Acute group..

Eur Psychiatry. 2011 May;26(4):252-9. doi: 10.1016/j.eurpsy.2010.11.005.

PMID:
21296559
20.

Do patients improve after short psychiatric admission?: a cohort study in Italy.

Barbato A, Parabiaghi A, Panicali F, Battino N, D'Avanzo B, de Girolamo G, Rucci P, Santone G; Progres-Acute Group..

Nord J Psychiatry. 2011 Sep;65(4):251-8. doi: 10.3109/08039488.2010.533387.

PMID:
21062122

Supplemental Content

Loading ...
Support Center